Clinical Trial Update: Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

View source ↗

Summary

The NSABP-B-45 trial studying biomarkers of fatigue in women with residual invasive breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer, Fatigue | Status: WITHDRAWN